United Therapeutics Corporatio - UTHR - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

United Therapeutics Corporatio - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
UTHR	Nasdaq	8731	http://www.unither.com	69.17 +0.69
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for United Therapeutics Corporatio Innovative Therapeutic Development for Duchenne Muscular Dystrophy Moves Niche Stocks Up 300% to 400%: An Expert Portfolio Manager Discusses Investing in Health Care - May 16th, 2013 11:31 am Organovo: Get Rich Or Die Tryin' - May 15th, 2013 7:13 am United Therapeutics downgraded by Standpoint Research - May 15th, 2013 3:40 am United Stock Hits New 52-Week High (UTHR) - May 14th, 2013 12:04 pm Gilead Shows Some Heart - May 8th, 2013 9:40 am Industry Ranks May 2013 - May 5th, 2013 10:33 pm Three Mid-Cap Stocks To Keep An Eye On - May 2nd, 2013 3:26 pm Alternative Generic Drug Products to Sustain Decent Margins and Cash Flow Generation Over the Long Term: Expert Analyst David Amsellem Discusses the Generic Drug Space with The Wall Street Transcript - May 2nd, 2013 9:11 am United Rises On Unusually High Volume (UTHR) - Apr 30th, 2013 2:14 pm Indexes Recover Early Losses As Turnover Picks Up - Apr 30th, 2013 11:35 am UNITED THERAPEUTICS CORP Financials - Apr 30th, 2013 11:04 am United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy - Apr 30th, 2013 2:19 am Investors Ride 5 Healthcare Earnings Rollercoaster Rides - Apr 28th, 2013 10:01 am Biogen Earnings Strong, But Celgene Just So-So - Apr 25th, 2013 3:39 pm United Therapeutics Management Discusses Q1 2013 Results - Earnings Call Transcript - Apr 25th, 2013 2:00 pm United Therapeutics Earnings: Here’s Why Investors are Selling Shares Now - Apr 25th, 2013 10:13 am 3 Top Biotechs Report Sharply Different Quarters - Apr 25th, 2013 8:52 am Q1 2013 United Therapeutics Earnings Release - Before Market Open - Apr 25th, 2013 5:07 am United Therapeutics Corporation Reports First Quarter 2013 Financial Results - Apr 25th, 2013 4:00 am UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition - Apr 24th, 2013 9:09 pm View All Current Headlines >>